中华眼视光学与视觉科学杂志
中華眼視光學與視覺科學雜誌
중화안시광학여시각과학잡지
CHINESE JOURNAL OF OPTOMETRY OPHTHALMOLOGY AND VISUAL SCIENCE
2013年
6期
377-380
,共4页
乔宝笛%陈鹏%帖彪%杜敏
喬寶笛%陳鵬%帖彪%杜敏
교보적%진붕%첩표%두민
后房%有晶状体眼%散光%人工晶状体
後房%有晶狀體眼%散光%人工晶狀體
후방%유정상체안%산광%인공정상체
Posterior chamber%Phakic%Astigmatism%Intraocular lens
目的 观察植入后房型有晶状体眼散光型人工晶状体矫正散光的临床效果.方法 前瞻性系列病例研究.选取伴有散光的中高度近视患者61例(113眼),进行后房型有晶状体眼散光型人工晶状体植入术(TICL),于术后1、3、6个月及1、2年进行手术的安全性、有效性、可预测性、稳定性及并发症的观察.手术前后不同时间点间的最佳矫正视力(BCVA)、裸眼视力(UCVA)、眼压与角膜内皮细胞密度的总体差异比较采用重复测量的单因素方差分析,两两时间点比较采用SNK-q检验.结果 术前BCVA为4.98±0.12,术后1、3、6个月及术后1、2年BCVA分别为5.04±0.08、5.02±0.09、5.05±0.10、5.04±0.09、5.03±0.11,各个时间点的BCVA差异均无统计学意义(F=2.090,P＞0.05).术前UCVA为4.03±0.07,术后各时间点UCVA分别为4.92±0.10、4.96±0.09、4.95±0.12、4.94±0.11、4.94±0.08,术后各个时间点的UCVA均较术前有显著提高(F=6.508,P＜0.05).术后屈光度较稳定,散光度均在0.5 D以内;TICL在眼内稳定,术后6个月时106眼(93.8％)旋转小于5°,7眼(6.2％)旋转在5°～10°之间.术中术后未发现严重并发症.结论 后房型有晶状体眼散光型人工晶状体植入术矫正散光安全、有效,可预测性及稳定性好.
目的 觀察植入後房型有晶狀體眼散光型人工晶狀體矯正散光的臨床效果.方法 前瞻性繫列病例研究.選取伴有散光的中高度近視患者61例(113眼),進行後房型有晶狀體眼散光型人工晶狀體植入術(TICL),于術後1、3、6箇月及1、2年進行手術的安全性、有效性、可預測性、穩定性及併髮癥的觀察.手術前後不同時間點間的最佳矯正視力(BCVA)、裸眼視力(UCVA)、眼壓與角膜內皮細胞密度的總體差異比較採用重複測量的單因素方差分析,兩兩時間點比較採用SNK-q檢驗.結果 術前BCVA為4.98±0.12,術後1、3、6箇月及術後1、2年BCVA分彆為5.04±0.08、5.02±0.09、5.05±0.10、5.04±0.09、5.03±0.11,各箇時間點的BCVA差異均無統計學意義(F=2.090,P＞0.05).術前UCVA為4.03±0.07,術後各時間點UCVA分彆為4.92±0.10、4.96±0.09、4.95±0.12、4.94±0.11、4.94±0.08,術後各箇時間點的UCVA均較術前有顯著提高(F=6.508,P＜0.05).術後屈光度較穩定,散光度均在0.5 D以內;TICL在眼內穩定,術後6箇月時106眼(93.8％)鏇轉小于5°,7眼(6.2％)鏇轉在5°～10°之間.術中術後未髮現嚴重併髮癥.結論 後房型有晶狀體眼散光型人工晶狀體植入術矯正散光安全、有效,可預測性及穩定性好.
목적 관찰식입후방형유정상체안산광형인공정상체교정산광적림상효과.방법 전첨성계렬병례연구.선취반유산광적중고도근시환자61례(113안),진행후방형유정상체안산광형인공정상체식입술(TICL),우술후1、3、6개월급1、2년진행수술적안전성、유효성、가예측성、은정성급병발증적관찰.수술전후불동시간점간적최가교정시력(BCVA)、라안시력(UCVA)、안압여각막내피세포밀도적총체차이비교채용중복측량적단인소방차분석,량량시간점비교채용SNK-q검험.결과 술전BCVA위4.98±0.12,술후1、3、6개월급술후1、2년BCVA분별위5.04±0.08、5.02±0.09、5.05±0.10、5.04±0.09、5.03±0.11,각개시간점적BCVA차이균무통계학의의(F=2.090,P＞0.05).술전UCVA위4.03±0.07,술후각시간점UCVA분별위4.92±0.10、4.96±0.09、4.95±0.12、4.94±0.11、4.94±0.08,술후각개시간점적UCVA균교술전유현저제고(F=6.508,P＜0.05).술후굴광도교은정,산광도균재0.5 D이내;TICL재안내은정,술후6개월시106안(93.8％)선전소우5°,7안(6.2％)선전재5°～10°지간.술중술후미발현엄중병발증.결론 후방형유정상체안산광형인공정상체식입술교정산광안전、유효,가예측성급은정성호.
Objective To investigate the clinical effect on the correction of astigmatism with a posterior chamber phakic toric implantable collamer lens (TICL).Methods This was a prospective case study.Sixty-one patients (113 eyes) with moderate to high myopia who had undergone TICL implantation were evaluated before surgery and at 1,3,and 6 months and 1 and 2 years after surgery to assess the safety,efficacy,predictability,stability and adverse events of the surgery.A repeated measures ANOVA test and SNK-q test were used to compare data at different time points,including best corrected visual acuity (BCVA),uncorrected visual acuity (UCVA),intraocular pressure (IOP) arid the density of corneal endothelial cells.Results Preoperative mean BCVA was 4.98±0.12,postoperative mean BCVAs were 5.04 ±0.08,5.02 ±0.09,5.05 ±0.10,5.04 ±0.09 and 5.03 ±0.11,respectively,at 1,3,and 6 months and 1 and 2 years after surgery.There were no significant differences for the BCVAs at the different time points (F=2.090,P＞0.05).Preoperative mean UCVA was 4.03±0.07,postoperative UCVAs were 4.92±0.10,4.96±0.09,4.95±0.12,4.94±0.11,and 4.94±0.08 at different time points.All BCVAs were significantly different compared to BCVA before surgery (F=6.508,P＜0.05).Refractive status remained stable after surgery and astigmatism fell below 0.5 D.The TICL remained stable:106 eyes (93.8％) had rotation less than 5° and 7 eyes (6.2％) had rotation of 5°～10° when measured at 6 months after surgery.There were no serious complications during or after surgery.Conclusion Implantation of a TICL is safe and effective and provides predictable and stable refractive results in the treatment of astigmatism.
